Synovo GmbH is a pharmaceutical discovery services company providing services in:   

  • Synthetic chemistry
  • Pharmacology Cell engineering
  • Peptide modification   

An overview of our chemistry catalog can be downloaded here.  








Synovo participates in several projects of the FP7 (Links open in a new window):



VISION - Prolonged inhibition of semaphorine3a pathway via a bio-degradable implant towards a better therapy for visual sensory impairments


   VISION Logo


NOVO - Novel approaches for prevention and degeneration of pathogenic bacteria biofilms formed on medical devices e.g. catheters




NANOFOL - Folate-based nanobiodevices for integrated diagnosis/therapy targeting chronic inflammatory diseases




Synovo GmbH is official partner of the Seventh Framework Programme.


FP7 Logo

Synovo GmbH
Paul Ehrlich Str. 15
D-72076 Tübingen
Tel +49 (0) 7071 964325
Fax +49 (0) 7071 964326
Mail contact@synovo.com
© 2002-2011 Synovo GmbH